Alzheimer's Drug Development Pipeline: Positive Results, New Insight Position 2024 as 'Learning Year'

Alzheimer’s treatment studies offer hope as UNLV expert predicts new potential drugs, biomarkers will yield critical insight for future development.

Related Keywords

United States ,Americans ,Mariac Carrillo ,Jeffrey Cummings ,Department Of Brain Health ,Alzheimer Association ,School Of Integrated Health Sciences ,Translational Research Clinical Interventions ,Integrated Health ,Brain Health ,Translational Research ,Clinical Interventions ,Newswise ,Ideo Alzheimers Disease Clinical Trials Research ,University Of Nevada ,As Vegas Unlv ,